Veru
Price & Volume
Stats
See moreOpen | $3.33 |
Previous Close | $3.45 |
Day Range | $3.27-$3.40 |
52W Range | $2.64-$14.20 |
Market Cap | $49.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $16.8M |
Revenue Growth (YoY) | 18.3% |
Gross Profit (12 Mos) | $5.8M |
Diluted EPS | $6 |
News
See moreYahoo Finance • 3 days ago
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
Yahoo Finance • last month
Veru outlines Phase III plans for enobosarm and signals upcoming FDA clarity on lean mass preservation in obesity treatment
Yahoo Finance • last month
Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress
Yahoo Finance • 2 months ago
Veru Q3 2025 Earnings Preview
About
CEO | Dr. Mitchell S. Steiner F.A.C.S., M.D. |
CFO | Ms. Michele Greco CPA |
Address | 2916 North Miami Avenue, Miami, FL, United States, 33127 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 210 |
